[go: up one dir, main page]

DK0980251T3 - Tissue factor to influence blood vessel formation - Google Patents

Tissue factor to influence blood vessel formation

Info

Publication number
DK0980251T3
DK0980251T3 DK98933500T DK98933500T DK0980251T3 DK 0980251 T3 DK0980251 T3 DK 0980251T3 DK 98933500 T DK98933500 T DK 98933500T DK 98933500 T DK98933500 T DK 98933500T DK 0980251 T3 DK0980251 T3 DK 0980251T3
Authority
DK
Denmark
Prior art keywords
tissue factor
blood vessel
vessel formation
influence blood
influence
Prior art date
Application number
DK98933500T
Other languages
Danish (da)
Inventor
Peter Nawroth
Katsumi Nakagawa
Youming Zhang
Original Assignee
Merckle Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merckle Gmbh filed Critical Merckle Gmbh
Application granted granted Critical
Publication of DK0980251T3 publication Critical patent/DK0980251T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Instructional Devices (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The invention relates to the use of tissue factor for influencing, in particular activating, the formation of blood vessels, above all for wound healing.
DK98933500T 1997-05-09 1998-05-08 Tissue factor to influence blood vessel formation DK0980251T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19719652A DE19719652A1 (en) 1997-05-09 1997-05-09 Use of tissue factor
DEPCT/DE98/01278 1998-05-07
PCT/DE1998/001306 WO1998051321A1 (en) 1997-05-09 1998-05-08 Tissue factor for influencing blood vessel formation

Publications (1)

Publication Number Publication Date
DK0980251T3 true DK0980251T3 (en) 2002-11-18

Family

ID=7829124

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98933500T DK0980251T3 (en) 1997-05-09 1998-05-08 Tissue factor to influence blood vessel formation

Country Status (16)

Country Link
EP (1) EP0980251B1 (en)
JP (1) JP2001527555A (en)
AT (1) ATE222501T1 (en)
AU (1) AU746782B2 (en)
CA (1) CA2288117A1 (en)
CZ (1) CZ293005B6 (en)
DE (2) DE19719652A1 (en)
DK (1) DK0980251T3 (en)
ES (1) ES2184299T3 (en)
HU (1) HUP0003831A3 (en)
IS (1) IS5231A (en)
NO (1) NO995459D0 (en)
PL (1) PL336662A1 (en)
PT (1) PT980251E (en)
SI (1) SI0980251T1 (en)
WO (1) WO1998051321A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060235209A9 (en) 1997-03-10 2006-10-19 Jin-An Jiao Use of anti-tissue factor antibodies for treating thromboses
US7749498B2 (en) 1997-03-10 2010-07-06 Genentech, Inc. Antibodies for inhibiting blood coagulation and methods of use thereof
US20030109680A1 (en) 2001-11-21 2003-06-12 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
US5986065A (en) 1997-03-10 1999-11-16 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
DE19719652A1 (en) * 1997-05-09 1998-12-03 Merckle Gmbh Use of tissue factor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770209A (en) * 1991-08-30 1998-06-23 University Of South Florida Acceleration of wound healing using connective tissue growth factor
AU5093593A (en) * 1992-08-28 1994-03-29 Scripps Research Institute, The Inhibition of tumor metastasis via neutralization of tissue factor function
FR2696095B1 (en) * 1992-09-30 1994-11-25 Inoteb Biological glue based on proteins coagulable by thrombin, enriched in platelet factors, its preparation and its application.
NZ271488A (en) * 1994-07-12 1998-01-26 Human Genome Sciences Inc Connective tissue growth factor-2 (ctgf-2)
US5981471A (en) * 1997-02-06 1999-11-09 Entremed, Inc. Compositions and methods for inhibiting cellular proliferation
DE19719652A1 (en) * 1997-05-09 1998-12-03 Merckle Gmbh Use of tissue factor

Also Published As

Publication number Publication date
AU8331598A (en) 1998-12-08
HUP0003831A2 (en) 2001-02-28
EP0980251B1 (en) 2002-08-21
DE19719652A1 (en) 1998-12-03
CA2288117A1 (en) 1998-11-19
NO995459L (en) 1999-11-08
CZ391299A3 (en) 2000-04-12
PT980251E (en) 2003-01-31
WO1998051321A1 (en) 1998-11-19
WO1998051321A9 (en) 1999-04-01
PL336662A1 (en) 2000-07-03
IS5231A (en) 1999-10-26
ATE222501T1 (en) 2002-09-15
JP2001527555A (en) 2001-12-25
CZ293005B6 (en) 2004-01-14
DE59805246D1 (en) 2002-09-26
SI0980251T1 (en) 2003-02-28
NO995459D0 (en) 1999-11-08
HUP0003831A3 (en) 2003-08-28
AU746782B2 (en) 2002-05-02
ES2184299T3 (en) 2003-04-01
EP0980251A1 (en) 2000-02-23

Similar Documents

Publication Publication Date Title
NO944997D0 (en) Thrombin blood fraction for use in a medical procedure
DE60023043D1 (en) (S, S) reboxetine for the treatment of incontinence
TR199901172T2 (en) Newly substituted pyrazole derivatives.
DE69827192D1 (en) Stent and stent-graft for the treatment of branched blood vessels
DK2412368T3 (en) Composition for the treatment of scars
DE69022249D1 (en) Bone wax applicator for the treatment of bone tissue.
TR199901174T2 (en) New heterocyclylmethyl-substituted pyrazole derivatives.
TR199801390T2 (en) Anticoagulants to be used in the treatment of thrombosis
NO971341L (en) Promoter for receptor tyrosine kinase TIE
DK0706348T3 (en) Surgical instrument especially for dental surgery.
DE50010284D1 (en) MEDICAMENT FOR THE TREATMENT OF BLOOD HIGH PRESSURE
DE69617963D1 (en) TITANIUM DIOXIDE BLADE TREATMENT TREATMENT
DK1178726T3 (en) Aqueous solution for preserving tissues and organs
DK0980251T3 (en) Tissue factor to influence blood vessel formation
DK1331940T3 (en) Use of the long pentraxin PTX3 in the treatment of diseases caused by altered activation of the growth factor FGF-2
DE3772051D1 (en) PROSTHESIS FOR EXPANSION OF SKIN TISSUE.
DE3785555D1 (en) USE OF GUAIFENESINE FOR THE TREATMENT OF UROLOGICAL COMPLAINTS.
ATE324905T1 (en) USE OF PLGF TO PREVENT OR TREAT SCHAEMIA OR STROKE
DE69519219D1 (en) Use of (2S, 4S) -6-fluoro-2 ', 5'-dioxospiro [chroman-4,4'-imidazoline] -2-carboxamide for the treatment of keratopathy
DE69832075D1 (en) USE OF EPROSARTAN FOR THE TREATMENT OF ISOLATED SYSTOLIC BLOOD HIGH PRESSURE
FR2698534B1 (en) Modular external fixator for osteosynthesis of small bones, especially of the hand.
NO984965D0 (en) Component B as cicatrisant
DE69819503D1 (en) USE OF 7-APHA-METHYL-17-ALPHA-ETHYNYL-ESTRANE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSE
UA32315A (en) Technique for skin suturing
EP1483396A4 (en) WIT 3.0, NEW GENUS TO CONTROL THE WOUND HEALING OF SOFT TISSUE